Amneal Pharmaceuticals, Inc. AMRX Other Working Capital
Other Working Capital at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s other working capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s other working capital?
- Amneal Pharmaceuticals, Inc. (AMRX) reported other working capital of -$1.49M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s other working capital changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s other working capital decreased by 13.2% year-over-year, from -$1.31M to -$1.49M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s other working capital?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s other working capital has grown at a -4.3% compound annual growth rate (CAGR), from -$5.63M to -$4.73M.
- What does other working capital mean?
- Net change in working capital items not separately classified — a residual balancing item.